Navigation Links
Daily aspirin usage associated with lower cancer mortality
Date:8/10/2012

Daily aspirin usage is associated with lower overall cancer mortality, but the association may be smaller than what was previously believed, according to a study published August 10 in the Journal of the National Cancer Institute.

A recent pooled analysis of randomized trials looking at the effects of daily aspirin use as a preventive measure for vascular events found a significant decrease in overall cancer mortality, of 37%, during a 5-year follow-up analysis, and 15% during a ten-year follow-up. Despite this finding, the effects of long-term daily aspirin use on cancer mortality remain largely unknown.

In order to determine the effects that long-term daily aspirin use has on overall cancer mortality, Eric J. Jacobs, Ph.D., of the Epidemiology Research Program at the American Cancer Society in Atlanta and colleagues looked at data on 100,139 men and women from the Cancer Prevention Study II Nutrition Cohort who had no prior history of cancer and had been taking a daily dose of aspirin. They used follow-up questionnaires to investigate peoples' aspirin intake.

The researchers found that among 5,138 participants who died because of cancer, daily aspirin usage was linked with slightly lower cancer mortality and was unrelated to the length of daily use. "Our results are consistent with an association between recent daily aspirin use and modestly lower cancer mortality," the authors write. However, the estimated reduced risk of 16% was much lower than the 37% reduction seen during the five-year follow-up period in the pooled analysis. Still, the researchers write, "Even a relatively modest benefit with respect to overall cancer mortality could still meaningfully influence the balances of risk and benefits of prophylactic aspirin use."

The authors do point out a potential limitation of their studynamely that it was an observational study, not a randomized trial, so they could have either underestimated or overestimated the size of reduction in cancer mortality from aspirin usage because of confounding factors.

In an accompanying editorial, John A. Baron, M.D., of the Department of Medicine at the University of North Carolina School of Medicine writes that the findings of the study reinforce the idea that there is a link between daily aspirin use and reduced cancer mortality. "The drug clearly reduces the incidence and mortality from luminal gastrointestinal cancers, and it may similarly affect other cancers," he writes, and noted that the findings from the American Cancer Society study may be "conservative." However, he cautions that, "As for any preventative intervention, the benefits must be balanced against the risks, particularly when the benefits are delayed whereas the risks are not."


'/>"/>
Contact: Zachary Rathner
Zachary.Rathner@oup.com
301-841-1286
Journal of the National Cancer Institute
Source:Eurekalert

Related medicine news :

1. Study adds to evidence daily aspirin linked to lower cancer mortality
2. Intuitive Number Sense Makes Daily Life Easier
3. Some Diabetics May Not Benefit From Daily Aspirin
4. Daily Coffee May Help Keep Grim Reaper Away
5. How the brains daily clock controls mood: A new project
6. U.S. Children Exposed to Hours of Background TV Daily
7. Women Less Apt Than Men to Get Recommended Daily Exercise
8. Aspirin protects against Barretts esophagus
9. Aspirin as Effective as Warfarin for Heart Failure: Study
10. Report says new evidence could tip the balance in aspirin cancer prevention care
11. Fertility drug usage and cancer risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/8/2016)... ... December 08, 2016 , ... Premier Fitness Camp (PFC) and ... the ultimate weight loss and wellness program, at their world headquarters of Omni La ... immediate and long-term results to anyone seeking weight loss, personal development, a healthy lifestyle, ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... continuity to its innovative Unified Instance Manager architecture, meeting the needs of ... new version optimizes the unattended auto-dialing system without agents, Presence Robodialer, provides ...
(Date:12/8/2016)... ... 08, 2016 , ... STATEN ISLAND, N.Y., Nov. 24, 2016 ... the highest standards of trauma, maternity, cancer and chronic obstructive pulmonary disease (COPD) ... Dr. Daniel Messina. , Among the recognitions, the American College of Surgeons' (ACS) ...
(Date:12/8/2016)... ... December 08, 2016 , ... California Senate Bill (SB) 863, signed into law ... in 2013 and 2014, according to CompScope™ Medical Benchmarks for California, 17th Edition ... to the study, medical payments per claim in California decreased 4 percent in 2013 ...
(Date:12/8/2016)... ... December 08, 2016 , ... ... Care Act. Dr. Botelho advocates for the mass media launching of story movements ... ongoing opportunities to share their unfortunate experiences; such a movement can generate the ...
Breaking Medicine News(10 mins):
(Date:12/8/2016)... , Dec. 8, 2016 Henry Schein, Inc. (Nasdaq: ... care products and services to office-based dental, animal health and ... equity investment in Marrodent, one of Poland,s ... $32 million. This transaction was announced on August 30, 2016. ... Poland since 2014, and Marrodent marks ...
(Date:12/8/2016)... 2016 Research and Markets has announced the addition ... to their offering. ... The report provides separate comprehensive analytics for ... and Rest of World. Annual estimates and forecasts are ... is provided for these markets. Market data and analytics are derived from ...
(Date:12/7/2016)... -- "Lantus (Insulin Glargine) Biosimilar Clinical Trial & Opportunity Insight" report by ... drug in clinical pipeline. Currently 5 biosimilar version of Lantus are commercially ... Kenya , Czech Republic , ... , Slovakia , United Kingdom ... patent on Lantus expired in 2014. Lantus is the brand name ...
Breaking Medicine Technology: